AustralieFrV1, Main, Exploration, bibRecord, 007A76

A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)

Identifieur interne : 007A76 ( Main/Exploration ); précédent : 007A75; suivant : 007A77

A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)

Auteurs : J. R. Davidson [États-Unis] ; W. Zhang [États-Unis] ; K. M. Connor [États-Unis] ; J. Ji [République populaire de Chine] ; K. Jobson [États-Unis] ; Y. Lecrubier [France] ; A. C. Mcfarlane [Australie] ; D. J. Newport [États-Unis] ; D. J. Nutt [Royaume-Uni] ; D. N. Osser [États-Unis] ; D. J. Stein [Afrique du Sud] ; Z. N. Stowe [États-Unis] ; O. Tajima [Japon] ; M. Versiani [Brésil]

Source :

Journal of psychopharmacology : (Oxford) [ 0269-8811 ] ; 2010.

RBID : Pascal:11-0027558

Descripteurs français

Pascal (Inist)
- Pharmacothérapie, Programme thérapeutique, Trouble de l'anxiété généralisée, Algorithme, Psychopharmacologie.

English descriptors

KwdEn :
- Algorithm, Generalized anxiety disorder, Pharmacotherapy, Psychopharmacology, Therapeutic schedule.

Abstract

Generalised anxiety disorder (GAD) is defined as excessive and uncontrollable worry and anxiety about everyday life situations. It is a chronic disorder, and is associated with substantial somatisation, high rates of comorbid depression and other anxiety disorders, and significant disability. The evidence base for pharmacotherapy and psychotherapy has continued to grow, and a wide range of drug choices for GAD now exists. Current guidelines for GAD generally restrict themselves to presentation of the evidence for various treatments, which, as a result, generally do not offer detailed discussion or recommendation of strategies beyond the first level of treatment, or take into account the individual circumstances of the patient. Thus, there is a lack of algorithm-based treatment guidelines for GAD. Our aim is, therefore, to present an algorithm for the psychopharmacologic management of GAD, intended for all clinicians who treat patients with GAD, where issues of pharmacotherapy are under consideration. We also hope that these GAD algorithms and other guidelines can help to identify high-priority areas that need further study. In this algorithm, we provide a sequenced approach to the pharmacotherapy of GAD, taking into account salient symptomatology and comorbidity, levels of evidence and extent of response. Special issues, including comorbidity, insomnia, suicidality, substance abuse, treatment adherence, pregnancy and lactation, cross-cultural issues, use of medication in the elderly, psychosocial treatment and dosing issues are also addressed.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 002129
to stream PascalFrancis, to step Corpus: 002239
to stream PascalFrancis, to step Curation: 003D98
to stream PascalFrancis, to step Checkpoint: 002654
to stream Main, to step Merge: 008122
to stream Main, to step Curation: 007A76

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)</title>
<author><name sortKey="Davidson, J R" sort="Davidson, J R" uniqKey="Davidson J" first="J. R." last="Davidson">J. R. Davidson</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Psychiatry and Behavioral Sciences, Duke University Medical Center</s1>
<s2>Durham, NC</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Durham, NC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zhang, W" sort="Zhang, W" uniqKey="Zhang W" first="W." last="Zhang">W. Zhang</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Psychiatry and Behavioral Sciences, Duke University Medical Center</s1>
<s2>Durham, NC</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Durham, NC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Connor, K M" sort="Connor, K M" uniqKey="Connor K" first="K. M." last="Connor">K. M. Connor</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Neuroscience and Ophthalmology, Merck Research Laboratories, Merck & Co., Inc.</s1>
<s2>North Wales, PA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>North Wales, PA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ji, J" sort="Ji, J" uniqKey="Ji J" first="J." last="Ji">J. Ji</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Mental Health, Shanghai Medical School, Fudan University; Department of Psychological Medicine, Zhongshan Hospital</s1>
<s2>Shanghai</s2>
<s3>CHN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jobson, K" sort="Jobson, K" uniqKey="Jobson K" first="K." last="Jobson">K. Jobson</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Department of Psychiatry, University of Tennessee</s1>
<s2>Knoxville, TN</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Knoxville, TN</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lecrubier, Y" sort="Lecrubier, Y" uniqKey="Lecrubier Y" first="Y." last="Lecrubier">Y. Lecrubier</name>
<affiliation wicri:level="3"><inist:fA14 i1="06"><s1>European College of Neuropsychopharmocology, Hôpital La Salpetriere</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mcfarlane, A C" sort="Mcfarlane, A C" uniqKey="Mcfarlane A" first="A. C." last="Mcfarlane">A. C. Mcfarlane</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>The University of Adelaide, Centre for Military and Veterans' Health</s1>
<s2>Adelaide, SA</s2>
<s3>AUS</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Adelaide, SA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Newport, D J" sort="Newport, D J" uniqKey="Newport D" first="D. J." last="Newport">D. J. Newport</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Women's Mental Health Program, Emory University School of Medicine</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Atlanta, GA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nutt, D J" sort="Nutt, D J" uniqKey="Nutt D" first="D. J." last="Nutt">D. J. Nutt</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Psychopharmacology Unit, Department of Community-based Medicine, University of Bristol</s1>
<s2>Bristol</s2>
<s3>GBR</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Bristol</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Osser, D N" sort="Osser, D N" uniqKey="Osser D" first="D. N." last="Osser">D. N. Osser</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Department of Psychiatry, Harvard Medical School, VA Boston Healthcare System</s1>
<s2>Brockton, MA</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Brockton, MA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stein, D J" sort="Stein, D J" uniqKey="Stein D" first="D. J." last="Stein">D. J. Stein</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Department of Psychiatry and Mental Health, University of Capetown</s1>
<s2>Cape Town</s2>
<s3>ZAF</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Afrique du Sud</country>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stowe, Z N" sort="Stowe, Z N" uniqKey="Stowe Z" first="Z. N." last="Stowe">Z. N. Stowe</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Women's Mental Health Program, Emory University School of Medicine</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Atlanta, GA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tajima, O" sort="Tajima, O" uniqKey="Tajima O" first="O." last="Tajima">O. Tajima</name>
<affiliation wicri:level="3"><inist:fA14 i1="13"><s1>Department of Mental Health, Kyorin University, School of Health Sciences</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Versiani, M" sort="Versiani, M" uniqKey="Versiani M" first="M." last="Versiani">M. Versiani</name>
<affiliation wicri:level="3"><inist:fA14 i1="14"><s1>Institute of Psychiatry, Federal University of Rio de Janeiro</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Brésil</country>
<placeName><settlement type="city">Rio de Janeiro</settlement>
<region type="state">État de Rio de Janeiro</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">11-0027558</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 11-0027558 INIST</idno>
<idno type="RBID">Pascal:11-0027558</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002129</idno>
<idno type="stanalyst">FRANCIS 11-0027558 INIST</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002239</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003D98</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002654</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">002654</idno>
<idno type="wicri:doubleKey">0269-8811:2010:Davidson J:a:psychopharmacological:treatment</idno>
<idno type="wicri:Area/Main/Merge">008122</idno>
<idno type="wicri:Area/Main/Curation">007A76</idno>
<idno type="wicri:Area/Main/Exploration">007A76</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)</title>
<author><name sortKey="Davidson, J R" sort="Davidson, J R" uniqKey="Davidson J" first="J. R." last="Davidson">J. R. Davidson</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Psychiatry and Behavioral Sciences, Duke University Medical Center</s1>
<s2>Durham, NC</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Durham, NC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zhang, W" sort="Zhang, W" uniqKey="Zhang W" first="W." last="Zhang">W. Zhang</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Psychiatry and Behavioral Sciences, Duke University Medical Center</s1>
<s2>Durham, NC</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Durham, NC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Connor, K M" sort="Connor, K M" uniqKey="Connor K" first="K. M." last="Connor">K. M. Connor</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Neuroscience and Ophthalmology, Merck Research Laboratories, Merck & Co., Inc.</s1>
<s2>North Wales, PA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>North Wales, PA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ji, J" sort="Ji, J" uniqKey="Ji J" first="J." last="Ji">J. Ji</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Mental Health, Shanghai Medical School, Fudan University; Department of Psychological Medicine, Zhongshan Hospital</s1>
<s2>Shanghai</s2>
<s3>CHN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jobson, K" sort="Jobson, K" uniqKey="Jobson K" first="K." last="Jobson">K. Jobson</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Department of Psychiatry, University of Tennessee</s1>
<s2>Knoxville, TN</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Knoxville, TN</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lecrubier, Y" sort="Lecrubier, Y" uniqKey="Lecrubier Y" first="Y." last="Lecrubier">Y. Lecrubier</name>
<affiliation wicri:level="3"><inist:fA14 i1="06"><s1>European College of Neuropsychopharmocology, Hôpital La Salpetriere</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mcfarlane, A C" sort="Mcfarlane, A C" uniqKey="Mcfarlane A" first="A. C." last="Mcfarlane">A. C. Mcfarlane</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>The University of Adelaide, Centre for Military and Veterans' Health</s1>
<s2>Adelaide, SA</s2>
<s3>AUS</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Adelaide, SA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Newport, D J" sort="Newport, D J" uniqKey="Newport D" first="D. J." last="Newport">D. J. Newport</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Women's Mental Health Program, Emory University School of Medicine</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Atlanta, GA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nutt, D J" sort="Nutt, D J" uniqKey="Nutt D" first="D. J." last="Nutt">D. J. Nutt</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Psychopharmacology Unit, Department of Community-based Medicine, University of Bristol</s1>
<s2>Bristol</s2>
<s3>GBR</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Bristol</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Osser, D N" sort="Osser, D N" uniqKey="Osser D" first="D. N." last="Osser">D. N. Osser</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Department of Psychiatry, Harvard Medical School, VA Boston Healthcare System</s1>
<s2>Brockton, MA</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Brockton, MA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stein, D J" sort="Stein, D J" uniqKey="Stein D" first="D. J." last="Stein">D. J. Stein</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Department of Psychiatry and Mental Health, University of Capetown</s1>
<s2>Cape Town</s2>
<s3>ZAF</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Afrique du Sud</country>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stowe, Z N" sort="Stowe, Z N" uniqKey="Stowe Z" first="Z. N." last="Stowe">Z. N. Stowe</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Women's Mental Health Program, Emory University School of Medicine</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Atlanta, GA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tajima, O" sort="Tajima, O" uniqKey="Tajima O" first="O." last="Tajima">O. Tajima</name>
<affiliation wicri:level="3"><inist:fA14 i1="13"><s1>Department of Mental Health, Kyorin University, School of Health Sciences</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Versiani, M" sort="Versiani, M" uniqKey="Versiani M" first="M." last="Versiani">M. Versiani</name>
<affiliation wicri:level="3"><inist:fA14 i1="14"><s1>Institute of Psychiatry, Federal University of Rio de Janeiro</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Brésil</country>
<placeName><settlement type="city">Rio de Janeiro</settlement>
<region type="state">État de Rio de Janeiro</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of psychopharmacology : (Oxford)</title>
<title level="j" type="abbreviated">J. psychopharmacol. : (Oxf.)</title>
<idno type="ISSN">0269-8811</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of psychopharmacology : (Oxford)</title>
<title level="j" type="abbreviated">J. psychopharmacol. : (Oxf.)</title>
<idno type="ISSN">0269-8811</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Algorithm</term>
<term>Generalized anxiety disorder</term>
<term>Pharmacotherapy</term>
<term>Psychopharmacology</term>
<term>Therapeutic schedule</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Pharmacothérapie</term>
<term>Programme thérapeutique</term>
<term>Trouble de l'anxiété généralisée</term>
<term>Algorithme</term>
<term>Psychopharmacologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Generalised anxiety disorder (GAD) is defined as excessive and uncontrollable worry and anxiety about everyday life situations. It is a chronic disorder, and is associated with substantial somatisation, high rates of comorbid depression and other anxiety disorders, and significant disability. The evidence base for pharmacotherapy and psychotherapy has continued to grow, and a wide range of drug choices for GAD now exists. Current guidelines for GAD generally restrict themselves to presentation of the evidence for various treatments, which, as a result, generally do not offer detailed discussion or recommendation of strategies beyond the first level of treatment, or take into account the individual circumstances of the patient. Thus, there is a lack of algorithm-based treatment guidelines for GAD. Our aim is, therefore, to present an algorithm for the psychopharmacologic management of GAD, intended for all clinicians who treat patients with GAD, where issues of pharmacotherapy are under consideration. We also hope that these GAD algorithms and other guidelines can help to identify high-priority areas that need further study. In this algorithm, we provide a sequenced approach to the pharmacotherapy of GAD, taking into account salient symptomatology and comorbidity, levels of evidence and extent of response. Special issues, including comorbidity, insomnia, suicidality, substance abuse, treatment adherence, pregnancy and lactation, cross-cultural issues, use of medication in the elderly, psychosocial treatment and dosing issues are also addressed.</div>
</front>
</TEI>
<affiliations><list><country><li>Afrique du Sud</li>
<li>Australie</li>
<li>Brésil</li>
<li>France</li>
<li>Japon</li>
<li>Royaume-Uni</li>
<li>République populaire de Chine</li>
<li>États-Unis</li>
</country>
<region><li>Région de Kantō</li>
<li>État de Rio de Janeiro</li>
<li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
<li>Rio de Janeiro</li>
<li>Tokyo</li>
</settlement>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Davidson, J R" sort="Davidson, J R" uniqKey="Davidson J" first="J. R." last="Davidson">J. R. Davidson</name>
</noRegion>
<name sortKey="Connor, K M" sort="Connor, K M" uniqKey="Connor K" first="K. M." last="Connor">K. M. Connor</name>
<name sortKey="Jobson, K" sort="Jobson, K" uniqKey="Jobson K" first="K." last="Jobson">K. Jobson</name>
<name sortKey="Newport, D J" sort="Newport, D J" uniqKey="Newport D" first="D. J." last="Newport">D. J. Newport</name>
<name sortKey="Osser, D N" sort="Osser, D N" uniqKey="Osser D" first="D. N." last="Osser">D. N. Osser</name>
<name sortKey="Stowe, Z N" sort="Stowe, Z N" uniqKey="Stowe Z" first="Z. N." last="Stowe">Z. N. Stowe</name>
<name sortKey="Zhang, W" sort="Zhang, W" uniqKey="Zhang W" first="W." last="Zhang">W. Zhang</name>
</country>
<country name="République populaire de Chine"><noRegion><name sortKey="Ji, J" sort="Ji, J" uniqKey="Ji J" first="J." last="Ji">J. Ji</name>
</noRegion>
</country>
<country name="France"><region name="Île-de-France"><name sortKey="Lecrubier, Y" sort="Lecrubier, Y" uniqKey="Lecrubier Y" first="Y." last="Lecrubier">Y. Lecrubier</name>
</region>
</country>
<country name="Australie"><noRegion><name sortKey="Mcfarlane, A C" sort="Mcfarlane, A C" uniqKey="Mcfarlane A" first="A. C." last="Mcfarlane">A. C. Mcfarlane</name>
</noRegion>
</country>
<country name="Royaume-Uni"><noRegion><name sortKey="Nutt, D J" sort="Nutt, D J" uniqKey="Nutt D" first="D. J." last="Nutt">D. J. Nutt</name>
</noRegion>
</country>
<country name="Afrique du Sud"><noRegion><name sortKey="Stein, D J" sort="Stein, D J" uniqKey="Stein D" first="D. J." last="Stein">D. J. Stein</name>
</noRegion>
</country>
<country name="Japon"><region name="Région de Kantō"><name sortKey="Tajima, O" sort="Tajima, O" uniqKey="Tajima O" first="O." last="Tajima">O. Tajima</name>
</region>
</country>
<country name="Brésil"><region name="État de Rio de Janeiro"><name sortKey="Versiani, M" sort="Versiani, M" uniqKey="Versiani M" first="M." last="Versiani">M. Versiani</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007A76 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 007A76 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:11-0027558
   |texte=   A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)

A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri